259 related articles for article (PubMed ID: 18385020)
1. Osteonecrosis of the jaw.
Sari E; Bulut N; Altundag K
J Am Dent Assoc; 2008 Apr; 139(4):398; author reply 398-400. PubMed ID: 18385020
[No Abstract] [Full Text] [Related]
2. Incidence of osteonecrosis of the jaw in women with postmenopausal osteoporosis in the health outcomes and reduced incidence with zoledronic acid once yearly pivotal fracture trial.
Grbic JT; Landesberg R; Lin SQ; Mesenbrink P; Reid IR; Leung PC; Casas N; Recknor CP; Hua Y; Delmas PD; Eriksen EF;
J Am Dent Assoc; 2008 Jan; 139(1):32-40. PubMed ID: 18167382
[TBL] [Abstract][Full Text] [Related]
3. [Bisphosphonates-related jaw osteonecrosis].
Abi Najm S; Lysitsa S; Carrel JP; Lesclous P; Lombardi T; Samson J
Presse Med; 2005 Sep; 34(15):1073-7. PubMed ID: 16334883
[TBL] [Abstract][Full Text] [Related]
4. Osteonecrosis of the jaws in newly diagnosed multiple myeloma patients treated with zoledronic acid and thalidomide-dexamethasone.
Tosi P; Zamagni E; Cangini D; Tacchetti P; Di Raimondo F; Catalano L; D'Arco A; Ronconi S; Cellini C; Offidani M; Perrone G; Ceccolini M; Brioli A; Tura S; Baccarani M; Cavo M
Blood; 2006 Dec; 108(12):3951-2. PubMed ID: 17114572
[No Abstract] [Full Text] [Related]
5. [Bisphosphonates and osteonecrosis of the jaws in patients with myelomatosis].
Neumann B; Gregersen H
Ugeskr Laeger; 2006 May; 168(21):2078-9. PubMed ID: 16768928
[TBL] [Abstract][Full Text] [Related]
6. Intravenous bisphosphonates and osteonecrosis.
Greenberg MS
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 Sep; 98(3):259-60. PubMed ID: 15356460
[No Abstract] [Full Text] [Related]
7. [Avascular osteonecrosis of the jaws induced by diphosphonates].
Lannoy D; Decaudin B; Barrier F; Bemba M; Wierre L; Pignon JM; Horrent S; Résibois JP; Wetterwald M; Odou P
Therapie; 2006; 61(4):363-5. PubMed ID: 17124954
[No Abstract] [Full Text] [Related]
8. Bisphosphonates, as a new cause of drug-induced jaw osteonecrosis: an update.
Jimenez-Soriano Y; Bagan JV
Med Oral Patol Oral Cir Bucal; 2005 Jul; 10 Suppl 2():E88-91. PubMed ID: 15995577
[No Abstract] [Full Text] [Related]
9. [Osteonecrosis associated with the use of biphosphonates: Case report].
Anguita C T; Agurto P J; Roa E I; Laissle C G
Rev Med Chil; 2006 Sep; 134(9):1161-5. PubMed ID: 17171218
[TBL] [Abstract][Full Text] [Related]
10. The incidence of osteonecrosis of the jaw in patients receiving 5 milligrams of zoledronic acid: data from the health outcomes and reduced incidence with zoledronic acid once yearly clinical trials program.
Grbic JT; Black DM; Lyles KW; Reid DM; Orwoll E; McClung M; Bucci-Rechtweg C; Su G
J Am Dent Assoc; 2010 Nov; 141(11):1365-70. PubMed ID: 21037195
[TBL] [Abstract][Full Text] [Related]
11. [Diphosphonate therapy and osteonecrosis of the jaw].
Løkken P; Skoglund LA; Skjelbred P
Tidsskr Nor Laegeforen; 2007 Aug; 127(15):1945-7. PubMed ID: 17700737
[No Abstract] [Full Text] [Related]
12. Oral bisphosphonates and osteonecrosis of the jaw: are the MHRA recommendations appropriate?
Compston J
Menopause Int; 2007 Jun; 13(2):54-5. PubMed ID: 17540133
[No Abstract] [Full Text] [Related]
13. Bisphosphonate-induced osteonecrosis of the jaw requires early detection and intervention.
Gibbs SD; O'Grady J; Seymour JF; Prince HM
Med J Aust; 2005 Nov; 183(10):549-50. PubMed ID: 16296983
[No Abstract] [Full Text] [Related]
14. Osteonecrosis of the jaw.
Friedlander AH
J Am Dent Assoc; 2011 Apr; 142(4):370-1; author reply 372-4. PubMed ID: 21454841
[No Abstract] [Full Text] [Related]
15. Relationship between periodontal disease and systemic diseases.
Alexander RE
Tex Dent J; 2006 Feb; 123(2):139; author reply 139. PubMed ID: 16579501
[No Abstract] [Full Text] [Related]
16. Drug induced osteonecrosis of the jaws.
Weeda LW
J Tenn Dent Assoc; 2006; 86(2):18-9. PubMed ID: 16895006
[No Abstract] [Full Text] [Related]
17. More about osteonecrosis.
Finkelman RD; Clemons M; Bouganim N
J Am Dent Assoc; 2011 Apr; 142(4):371-2; author reply 372-4. PubMed ID: 21454842
[No Abstract] [Full Text] [Related]
18. [Diphosphonates can cause necrosis of the jaw. Patients with malignant skeletal diseases are at risk].
Jarnbring F; Ulmner M; Blomlöf J; Ljungman P
Lakartidningen; 2006 May 31-Jun 6; 103(21-22):1741-3. PubMed ID: 16826719
[No Abstract] [Full Text] [Related]
19. Bisphosphonates and osteonecrosis of the jaw: a case report.
Reiriz AB; De Zorzi Pde M; Lovat CP
Clinics (Sao Paulo); 2008 Apr; 63(2):281-4. PubMed ID: 18438586
[No Abstract] [Full Text] [Related]
20. Bisphosphonate-related osteonecrosis of the jaws: an update on clinical, pathological and management aspects.
Ficarra G; Beninati F
Head Neck Pathol; 2007 Dec; 1(2):132-40. PubMed ID: 20614264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
